Patents by Inventor Dongpo CAI

Dongpo CAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • APPLICATION OF SESQUITERPENE LACTONE COMPOUND IN PREPARATION OF DRUGS FOR ALLEVIATING RADIOTHERAPY-INDUCED INJURIES
    Publication number: 20230398092
    Abstract: A Sesquiterpene lactone compound, and a stereoisomer, isotopic marker, solvate and polymorph thereof, or a pharmaceutically acceptable salt thereof can be used in the preparation of drugs for alleviating radiotherapy-induced injuries. The Sesquiterpene lactone compound is applied to assist radiotherapy, can effectively alleviate the radiotherapy-induced injuries, achieves a protection effect on normal cell tissues of a human body.
    Type: Application
    Filed: October 20, 2021
    Publication date: December 14, 2023
    Inventors: Yue CHEN, Dongpo CAI, Shiqi BAO, Xuemei ZHANG, Jing CHEN, Jianmiao GONG, Jianshuang GUO, Jing LI
  • EGFR kinase inhibitor and preparation method and use thereof
    Patent number: 10710979
    Abstract: The present invention provides an EGFR kinase inhibitor and a preparation method and use thereof. Specifically, the present invention provides a compound as shown in formula (I), the definition of each group therein being as described in the description. Said compound is an efficient EGFR inhibitor.
    Type: Grant
    Filed: July 11, 2016
    Date of Patent: July 14, 2020
    Assignee: ZHEJIANG BOSSAN PHARMACEUTICAL CO. LTD.
    Inventors: Dawei Ma, Qiang Yu, Junying Yuan, Hongguang Xia, Dongpo Cai, Kailiang Wang, Chen Zhang, Shanghua Xia
  • EGFR KINASE INHIBITOR AND PREPARATION METHOD AND USE THEREOF
    Publication number: 20180346444
    Abstract: The present invention provides an EGFR kinase inhibitor and a preparation method and use thereof. Specifically, the present invention provides a compound as shown in formula (I), the definition of each group therein being as described in the description. Said compound is an efficient EGFR inhibitor.
    Type: Application
    Filed: July 11, 2016
    Publication date: December 6, 2018
    Inventors: Dawei MA, Qiang YU, Junying YUAN, Hongguang XIA, Dongpo CAI, Kailiang WANG, Chen ZHANG, Shanghua XIA